Walgreens Boots Alliance, Inc. (WBA) — 2024Q2 FY2024 Earnings Call Analysis

Four Guidance Cuts Offset by a Tax One-Timer

Management called positive EBITDA a milestone while writing off $12.4 billion of goodwill in the same quarter.

Thesis: Adjusted EPS of $1.20 looks like execution but is propped by a sub-5% tax rate from a new deferred tax asset, $600M in CapEx cuts, and $500M in working capital draws. Underneath, GAAP shows a $5.8B net loss, comp guidance was cut to -3%, sale-leaseback gains are gone, Sencora equity earnings are gone, and the $12.4B VillageMD impairment proves management overpaid for the growth story they're still telling. The 'positive EBITDA milestone' in US Healthcare is a rounding error beside the capital destroyed.

Verdict: SHORT — Conviction: HIGH

Catalyst: Management commits to a board portfolio review at end of April with potential asset sales or restructuring. If the review confirms the $1B cost savings wraparound into FY25 and Healthcare prints $100-200M adjusted EBITDA, the short thesis weakens.

Key Risk: Cost savings land on schedule and Boots UK keeps comping +5.9% with 12 straight quarters of share gains. That combination creates a floor under the stock while the market looks past the impairment.

The Tell: When asked about the Sencora distribution renegotiation, the response was pure deflection: 'relationship has always got to be organic and dynamic' with zero specifics on cost terms or timeline. Contrast with the same executive giving precise numbers on cost savings visibility. The vagueness on a material vendor relationship while boasting about internal numbers shows where confidence actually sits.

Detected Patterns

Say/Do Gap: Management leads with 'first quarter of positive adjusted EBITDA' as a milestone while booking a $12.4B goodwill impairment on a downward-revised VillageMD forecast in the same quarter. The growth thesis required clinic density; they just exited 140 of 160 locations.
Mix Shift Spin: Adjusted EPS of $1.20 absorbs a sub-5% tax rate from a newly recognized deferred tax asset plus pharmacy services strength, while GAAP shows a loss. Four separate guidance headwinds are offset by a one-time tax benefit.
Unsustainable Trend Confidence: Full risk lives grew 19%, but the density-based growth model was reversed with 140 clinic exits. The remaining offset is $1B cost cuts, $500M working capital benefits, and $600M CapEx reduction. Deferred spend and cuts, not revenue growth.

Friction Level: MODERATE_FRICTION — Both sides agree on the facts: four guidance headwinds and a $12.4B VillageMD write-down. The disagreement is whether the $1B cost savings and Boots UK strength are early-turnaround proof or just temporary offsets to structural US retail decline.

Report not found

The report data is no longer available. Please return to the archive.

Four Guidance Cuts Offset by a Tax One-Timer | Silicon Signal